Financhill
Buy
59

PYPD Quote, Financials, Valuation and Earnings

Last price:
$3.97
Seasonality move :
0.75%
Day range:
$3.87 - $3.98
52-week range:
$2.30 - $4.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.63x
Volume:
113K
Avg. volume:
98.2K
1-year change:
34.58%
Market cap:
$40.5M
Revenue:
--
EPS (TTM):
-$2.98

Analysts' Opinion

  • Consensus Rating
    PolyPid Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $12.25, PolyPid Ltd. has an estimated upside of 208.56% from its current price of $3.97.
  • Price Target Downside
    According to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $3.97.

Fair Value

  • According to the consensus of 3 analysts, PolyPid Ltd. has 208.56% upside to fair value with a price target of $12.25 per share.

PYPD vs. S&P 500

  • Over the past 5 trading days, PolyPid Ltd. has overperformed the S&P 500 by 0.19% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • PolyPid Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PolyPid Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter PolyPid Ltd. reported revenues of --.

Earnings Growth

  • PolyPid Ltd. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter PolyPid Ltd. reported earnings per share of -$0.37.
Enterprise value:
25.8M
EV / Invested capital:
1.31x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.63x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-135.57%
Net Income Margin (TTM):
--
Return On Equity:
-373.79%
Return On Invested Capital:
-196.11%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$23.5M -$25.8M -$32.7M -$7.4M -$7.5M
EBITDA -$23.5M -$25.8M -- -$7.4M --
Diluted EPS -$4.14 -$7.69 -$2.98 -$1.22 -$0.37
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $45.3M $19.8M $11.1M $10.4M $19.6M
Total Assets $53.5M $29.4M $20.9M $19.6M $26.8M
Current Liabilities $5.1M $6.9M $5.9M $10.5M $7.6M
Total Liabilities $5.3M $17.9M $17.4M $17.4M $11.5M
Total Equity $48.1M $11.5M $3.5M $2.2M $15.4M
Total Debt -- $11.5M $11.4M $9.1M $3.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-06-30 2023-06-30 2024-06-30 2023-06-30 2024-06-30
Cash Flow Statement
Cash Flow Operations -- -- -- -$8.3M -$8.5M
Cash From Investing -- -- -- -$7.9M -$6.2M
Cash From Financing -- -- -- $11M $12.5M
Free Cash Flow -$44.3M -$47.6M -$53.2M -$8.5M -$8.5M
PYPD
Sector
Market Cap
$40.5M
$28.5M
Price % of 52-Week High
98.11%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
3.94%
-1.33%
1-Year Price Total Return
34.58%
-20.32%
Beta (5-Year)
1.489
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $3.87
200-day SMA
Buy
Level $3.25
Bollinger Bands (100)
Buy
Level 3.32 - 3.72
Chaikin Money Flow
Sell
Level -16.5M
20-day SMA
Buy
Level $3.74
Relative Strength Index (RSI14)
Buy
Level 63.38
ADX Line
Buy
Level 16.37
Williams %R
Sell
Level -13.9982
50-day SMA
Buy
Level $3.58
MACD (12, 26)
Buy
Level 0.09
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 24.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-17.2623)
Sell
CA Score (Annual)
Level (-8.3551)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (9.3268)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.

Stock Forecast FAQ

In the current month, PYPD has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PYPD average analyst price target in the past 3 months is $12.25.

  • Where Will PolyPid Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PolyPid Ltd. share price will rise to $12.25 per share over the next 12 months.

  • What Do Analysts Say About PolyPid Ltd.?

    Analysts are divided on their view about PolyPid Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PolyPid Ltd. is a Sell and believe this share price will drop from its current level to $9.00.

  • What Is PolyPid Ltd.'s Price Target?

    The price target for PolyPid Ltd. over the next 1-year time period is forecast to be $12.25 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PYPD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PolyPid Ltd. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of PYPD?

    You can purchase shares of PolyPid Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PolyPid Ltd. shares.

  • What Is The PolyPid Ltd. Share Price Today?

    PolyPid Ltd. was last trading at $3.97 per share. This represents the most recent stock quote for PolyPid Ltd.. Yesterday, PolyPid Ltd. closed at $3.97 per share.

  • How To Buy PolyPid Ltd. Stock Online?

    In order to purchase PolyPid Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock